International Clinical Trial: Evaluation of the Effect of Amantadine in the Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889115) titled 'Evaluation of the Effect of Amantadine in the Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients' on Oct. 16.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Outcomes Assessor).

Primary Sponsor: Al-Azhar University

Condition: Breast Cancer Peripheral Neuropathy Due to Chemotherapy VAS Score

Intervention: Drug: Amantadine (oral)

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: December 1, 2026

Target Sample Size: 80

To know more, visit https://cl...